https://www.selleckchem.com/products/sc79.html
Mycoplasma genitalium is an emergent cause of sexually transmitted disease (STD). The first-line treatment is azithromycin, but macrolide resistance is increasing due to mutations in the 23S rRNA gene. To determine the rates of M. genitalium infection and macrolide resistance in an area adjacent to Barcelona. This 1 year prospective study was performed in a heterogenous population that included both low- and high-risk patients. M. genitalium was detected in all specimens sent to our institution for STD detection. Epidemiological and releva
Mi piace
Commento
Condividi
